Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1966 1
1967 3
1968 4
1969 4
1970 8
1971 19
1972 40
1973 133
1974 136
1975 217
1976 335
1977 333
1978 454
1979 513
1980 659
1981 793
1982 954
1983 1011
1984 1048
1985 1112
1986 1104
1987 1043
1988 999
1989 990
1990 990
1991 879
1992 860
1993 848
1994 786
1995 764
1996 714
1997 728
1998 707
1999 699
2000 732
2001 627
2002 611
2003 656
2004 612
2005 667
2006 692
2007 681
2008 710
2009 688
2010 692
2011 749
2012 713
2013 786
2014 808
2015 766
2016 856
2017 905
2018 938
2019 1022
2020 1080
2021 1087
2022 1062
2023 877
2024 337

Text availability

Article attribute

Article type

Publication date

Search Results

36,869 results

Results by year

Filters applied: . Clear all
Page 1
Naloxone treatment in opioid addiction: the risks and benefits.
van Dorp E, Yassen A, Dahan A. van Dorp E, et al. Expert Opin Drug Saf. 2007 Mar;6(2):125-32. doi: 10.1517/14740338.6.2.125. Expert Opin Drug Saf. 2007. PMID: 17367258 Review.
Risks related to naloxone use in opioid-dependent patients are: i) the induction of an acute withdrawal syndrome (the occurrence of vomiting and aspiration is potentially life threatening); ii) the effect of naloxone may wear off prematurely when used for treatment …
Risks related to naloxone use in opioid-dependent patients are: i) the induction of an acute withdrawal syndrome (the occurrence of v …
Naloxone.
Handal KA, Schauben JL, Salamone FR. Handal KA, et al. Ann Emerg Med. 1983 Jul;12(7):438-45. doi: 10.1016/s0196-0644(83)80343-6. Ann Emerg Med. 1983. PMID: 6309038 Review.
Naloxone hydrochloride, a synthetic N-allyl derivative of oxymorphone, is an effective agent for the reversal of the cardiovascular and respiratory depression associated with narcotic and possibly some non-narcotic overdoses. It is essentially a pure narcotic antagonist, i …
Naloxone hydrochloride, a synthetic N-allyl derivative of oxymorphone, is an effective agent for the reversal of the cardiovascular a …
Naloxone-associated morbidity and mortality.
Pallasch TJ, Gill CJ. Pallasch TJ, et al. Oral Surg Oral Med Oral Pathol. 1981 Dec;52(6):602-3. doi: 10.1016/0030-4220(81)90077-3. Oral Surg Oral Med Oral Pathol. 1981. PMID: 7031551 Review.
Naloxone (Narcan) is generally considered to be a narcotic antagonist devoid of pharmacologic activity except for its reversal of opioid (narcotic) effects. ...Any patient given naloxone, particularly in the presence of surgical pain, should be closely monitored for …
Naloxone (Narcan) is generally considered to be a narcotic antagonist devoid of pharmacologic activity except for its reversal of opi …
When Naloxone Isn't Enough.
Messmer S, Jarrett J. Messmer S, et al. N Engl J Med. 2022 May 26;386(21):1967-1969. doi: 10.1056/NEJMp2202387. Epub 2022 May 21. N Engl J Med. 2022. PMID: 35593723 No abstract available.
Naloxone.
Noerr B. Noerr B. Neonatal Netw. 1992 Jun;11(4):77-9. Neonatal Netw. 1992. PMID: 1608383 No abstract available.
[Naloxone].
Setoguchi D, Kakihana Y. Setoguchi D, et al. Masui. 2013 Jan;62(1):5-9. Masui. 2013. PMID: 23431888 Japanese.
Naloxone hydrochloride is an agent capable of antagonizing respiratory depression and analgesic actions which are inherent to the opioid by competitively acting at opioid receptors. ...Moreover, even though it has been confirmed in 1980's that naloxone has vasopress …
Naloxone hydrochloride is an agent capable of antagonizing respiratory depression and analgesic actions which are inherent to the opi …
Naloxone hydrochloride: a review.
Goodrich PM. Goodrich PM. AANA J. 1990 Feb;58(1):14-6. AANA J. 1990. PMID: 2180244 Review.
Naloxone hydrochloride is a widely used opioid antagonist. Narcotic analgesics administered to patients bind to opioid receptor sites within the central nervous system. ...Blocking of the receptor sites by opioid antagonists, such as naloxone hydrochloride, reverses …
Naloxone hydrochloride is a widely used opioid antagonist. Narcotic analgesics administered to patients bind to opioid receptor sites …
Buprenorphine-Naloxone Maintenance and Lactation.
Jansson LM, McConnell K, Velez M, Spencer N, Gomonit M, Swortwood MJ. Jansson LM, et al. J Hum Lact. 2024 Feb;40(1):113-119. doi: 10.1177/08903344231209304. Epub 2023 Nov 29. J Hum Lact. 2024. PMID: 38018534
RESEARCH AIMS: To determine the concentrations of buprenorphine and naloxone and their primary metabolites in human milk, maternal plasma, and infant plasma, among lactating buprenorphine-naloxone maintained people and their infants. ...Naloxone was not detec …
RESEARCH AIMS: To determine the concentrations of buprenorphine and naloxone and their primary metabolites in human milk, maternal pl …
Naloxone-Induced Noncardiogenic Pulmonary Edema.
Patti R, Ponnusamy V, Somal N, Sinha A, Sharma S, Yoon TS, Kupfer Y. Patti R, et al. Am J Ther. 2020 Nov/Dec;27(6):e672-e673. doi: 10.1097/MJT.0000000000001037. Am J Ther. 2020. PMID: 31789629 No abstract available.
36,869 results
You have reached the last available page of results. Please see the User Guide for more information.